Catalyst system based on a rare-earth metallocene and a co-catalyst having a plurality of carbon-magnesium bonds
US-2024117080-A1 · Apr 11, 2024 · US
US12565507B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12565507-B2 |
| Application number | US-202017785952-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 14, 2020 |
| Priority date | Dec 17, 2019 |
| Publication date | Mar 3, 2026 |
| Grant date | Mar 3, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A diorganomagnesium compound of formula R B —Mg—R A is provided. R B is different from R A , R B comprises a benzene nucleus substituted with a magnesium atom, one of the carbon atoms of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbour and which is meta to the magnesium. The other carbon atom of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl or an isopropyl. R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, which diorganomagnesium compound is other than n-butylmesitylmagnesium. When used as co-catalyst of a metallocene, it makes it possible to increase the functional group content in the synthesis of a functional polymer.
Opening claim text (preview).
The invention claimed is: 1 . An asymmetric diorganomagnesium compound of formula (I) R B —Mg—R A (I), R B being different from R A , R B comprising a benzene ring substituted with the magnesium atom, one of the carbon atoms of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbor and which is meta to the magnesium atom, the other carbon atom of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl or an isopropyl, R A being an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, wherein the diorganomagnesium compound is other than n-butylmesitylmagnesium. 2 . The asymmetric diorganomagnesium compound according to claim 1 , in which R A represents an alkyl containing from 2 to 10 carbon atoms. 3 . The asymmetric diorganomagnesium compound according to claim 1 , in which R A represents a linear alkyl. 4 . A process for preparing an asymmetric diorganomagnesium compound of formula R B —Mg—R A , which comprises the placing in contact of an organometallic compound of formula R A M with an organomagnesium agent of formula R B —Mg—X and the reaction of the organometallic compound of formula R A M and of the organomagnesium agent of formula R B —Mg—X, M representing a lithium, sodium or potassium atom, X representing a leaving group, R B being different from R A , R B comprising a benzene ring substituted with the magnesium atom, one of the carbon atoms of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbor and which is meta to the magnesium atom, the other carbon atom of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl or an isopropyl, R A being an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, said diorganomagnesium compound being other than n-butylmesitylmagnesium. 5 . The process according to claim 4 , in which X is a halogen atom. 6 . The process according to claim 4 , in which X is a bromine atom or a chlorine atom. 7 . The process according to claim 4 , in which M represents a lithium atom. 8 . The asymmetric diorganomagnesium compound according to claim 1 , in which the carbon atoms of the benzene ring of R B ortho to the magnesium atom are substituted with a methyl. 9 . The asymmetric diorganomagnesium compound according to claim 2 , in which R A represents an alkyl containing from 2 to 8 carbon atoms. 10 . The process according to claim 6 , in which X is a bromine atom. 11 . The process according to claim 4 , in which, if one of the two carbon atoms of the benzene ring of R B ortho to the magnesium atom is substituted with an isopropyl, the second carbon atom of the benzene ring of R B ortho to the magnesium atom is not substituted with an isopropyl. 12 . The process according to claim 4 , in which the carbon atoms of the benzene ring of R B ortho to the magnesium atom are substituted with a methyl or an ethyl. 13 . A process for preparing an asymmetric diorganomagnesium compound of formula (II) in which R 1 and R 5 represent a methyl or an ethyl, R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom or an alkyl, R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, which comprises the placing in contact of an organometallic compound of formula R A M with an organomagnesium agent of formula R B —Mg—X and the reaction of the organometallic compound of formula R A M and of the organomagnesium agent of formula R B —Mg—X, the organomagnesium agent of formula R B —Mg—X being of the formula: M representing a lithium, sodium or potassium atom, and X representing a leaving group, said diorganomagnesium compound of formula (II) being other than n-butylmesitylmagnesium. 14 . An asymmetric diorganomagnesium compound of formula (II) in which R 1 and R 5 represent a methyl or an ethyl, R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom or an alkyl, R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted said diorganomagnesium compound of formula (II) being other than n-butylmesitylmagnesium. 15 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 1 , R 3 and R 5 are identical. 16 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 2 and R 4 represent a hydrogen atom. 17 . The asymmetric diorganomagnesium compound according to claim 14 , in which R A represents an alkyl containing from 2 to 10 carbon atoms. 18 . The asymmetric diorganomagnesium compound according to claim 17 , in which R A represents an alkyl containing from 2 to 8 carbon atoms. 19 . The asymmetric diorganomagnesium compound according to claim 14 , in which R A represents a linear alkyl. 20 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 1 and R 5 represent a methyl.
Ethene · CPC title
Magnesium compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.